Can I Take L-Theanine with Farxiga (Dapagliflozin)?

The Short Answer on Safety

L-theanine and Farxiga do not share a metabolic pathway that would cause a classic drug-supplement interaction. Farxiga works by blocking the SGLT2 transporter in the kidney proximal tubule, flushing glucose into urine. L-theanine, an amino acid found in green tea, acts primarily on the central nervous system by modulating alpha brain-wave activity and influencing glutamate neurotransmission. These mechanisms do not collide in the way that, say, a CYP3A4 inhibitor and a CYP3A4-metabolized drug would.

"no pharmacokinetic clash" is not the same as "completely free of concern." A few indirect effects are worth knowing about, especially if you are managing blood pressure, blood sugar, or stress hormones alongside dapagliflozin.

What Farxiga Actually Does in Your Body

Dapagliflozin inhibits the sodium-glucose co-transporter 2 (SGLT2) in the renal proximal tubule, causing roughly 60-80 grams of glucose to be excreted in urine each day in patients with type 2 diabetes. Beyond glucose, the drug produces a modest natriuretic (sodium-losing) effect, which translates to a blood-pressure reduction of approximately 3-5 mmHg systolic on average. It also has well-established cardiovascular and renal benefits demonstrated in the DAPA-HF trial and the DAPA-CKD trial.

What L-Theanine Actually Does in Your Body

L-theanine (gamma-glutamylethylamide) is absorbed in the small intestine and crosses the blood-brain barrier via the leucine-preferring transport system. Once there, it increases alpha-wave activity, modulates GABA, and blunts the cortisol and heart-rate response to acute psychosocial stress. A 2019 randomized controlled trial in Nutrients found that 200 mg of L-theanine daily for four weeks reduced self-reported stress and salivary cortisol compared to placebo in healthy adults. Blood-pressure effects in the literature are small but consistent: a 2012 clinical trial found reductions in resting heart rate and blood pressure under psychological stress conditions in habitual tea drinkers given isolated L-theanine.

Pharmacokinetic Profile: Why These Two Drugs Don't Fight Over Enzymes

Dapagliflozin is metabolized primarily by UGT1A9 and to a minor extent UGT2B4, the glucuronidation pathway. It is not a CYP substrate, and it does not meaningfully induce or inhibit CYP enzymes. L-theanine is a free amino acid cleared renally after partial hepatic metabolism. It does not inhibit UGT enzymes at doses used clinically (100-400 mg/day).

This means there is no competition for the same enzyme, no inhibition of each other's clearance, and no induction of metabolic enzymes that could reduce either compound's effectiveness. The absence of a pharmacokinetic interaction is the most reassuring piece of data available.

Where the Data Is Thin (Honest Caveat)

No head-to-head pharmacokinetic study of L-theanine plus dapagliflozin has been published as of January 2025. The reassurance above is extrapolated from each compound's individual metabolic profile, not from a co-administration study. Women have historically been underrepresented in SGLT2 inhibitor trials, and supplement-drug interaction studies almost never include a female-majority cohort. This is a genuine evidence gap you deserve to know about.

The Pharmacodynamic Overlap That Does Matter

Even when two substances don't interact at the enzymatic level, they can still affect the same physiological outputs. For Farxiga and L-theanine, two overlapping outputs deserve attention.

Blood Pressure

Farxiga lowers blood pressure modestly through osmotic diuresis and natriuresis. L-theanine lowers blood pressure modestly through attenuation of the sympathetic stress response. Taking them together could, in theory, produce additive blood-pressure lowering. For most women, a few extra millimeters of mercury in the right direction is not a problem. But for women who already run low, who are elderly, or who are on ACE inhibitors, ARBs, or diuretics alongside Farxiga, additive hypotension becomes a real monitoring point.

Signs of hypotension to watch for include dizziness on standing (orthostatic hypotension), lightheadedness during exercise, or an unusual sense of fatigue in the first few weeks after adding L-theanine. Check your blood pressure at home for the first two weeks after combining these.

Blood Glucose (Much Lower Risk Than You Might Expect)

L-theanine does not significantly lower blood glucose on its own. A 2014 study in Phytomedicine found that L-theanine had no meaningful hypoglycemic effect in animal models at physiologically relevant doses. For practical purposes, you do not need to worry about L-theanine stacking hypoglycemic effects on top of dapagliflozin. Dapagliflozin itself carries a low intrinsic hypoglycemia risk (because it works downstream of insulin), and L-theanine does not worsen that risk.

Cortisol and Stress Hormones: A Women's-Health Angle

This is the piece most articles miss. Chronic stress elevates cortisol, which impairs insulin sensitivity and raises blood glucose. L-theanine's cortisol-blunting effect could, indirectly, support better glycemic control by reducing stress-induced glucose elevations. This is not a pharmacodynamic interaction in the traditional sense. It may actually be a mild, additive benefit for women whose glucose is stress-sensitive.

For women with PCOS specifically, where cortisol dysregulation, insulin resistance, and androgen excess often co-exist, the pairing of an SGLT2 inhibitor (used off-label for PCOS metabolic management) with L-theanine for stress and sleep is not inherently irrational. It just has not been formally studied in this population.

Women-Specific Considerations Across Life Stages

Reproductive Years and PCOS

Dapagliflozin is used off-label in PCOS to address insulin resistance and, in some cases, reduce androgen levels. A 2021 pilot trial in Fertility and Sterility examined SGLT2 inhibitors in women with PCOS and found improvements in HOMA-IR and free androgen index. If you are using Farxiga for PCOS and adding L-theanine for anxiety or sleep, the combination appears pharmacologically reasonable, though no trial has tested this exact pairing.

Women with PCOS who are also trying to conceive need to pay close attention to the next section.

Perimenopause and Postmenopause

Estrogen withdrawal in perimenopause and postmenopause worsens insulin resistance and shifts fat distribution toward visceral adiposity, increasing risk for type 2 diabetes and cardiovascular disease. Farxiga is approved for type 2 diabetes and heart failure, conditions that become more common after menopause. The modest blood-pressure benefit of Farxiga is especially relevant for postmenopausal women, in whom systolic hypertension is more prevalent.

Postmenopausal women also experience more orthostatic hypotension due to reduced vascular tone and autonomic changes. Adding L-theanine's mild blood-pressure-lowering effect deserves monitoring in this group. Check your blood pressure on standing versus sitting for the first two weeks.

Pregnancy: Farxiga Is Contraindicated

Farxiga must be stopped before pregnancy or as soon as pregnancy is confirmed. The FDA label for dapagliflozin carries a warning against use in the second and third trimesters based on animal data showing fetal renal toxicity and impaired renal development. Because SGLT2 transporters become active in fetal kidneys during the second trimester, any exposure after approximately 14-28 weeks poses a risk to fetal kidney development. ACOG and the manufacturer recommend stopping dapagliflozin before 28 weeks at the absolute latest, and most experts advise stopping prior to conception if possible.

If you are on Farxiga and could become pregnant, use reliable contraception. Discuss the transition plan with your endocrinologist or OB-GYN before stopping.

L-theanine in pregnancy has no controlled trial data in humans. Given the lack of safety data, most practitioners advise avoiding it during pregnancy, particularly in the first trimester. The risk is unknown, not confirmed safe.

Lactation

Dapagliflozin is not recommended during breastfeeding. Animal data show dapagliflozin is excreted in breast milk, and given that the neonatal kidney depends on SGLT2 activity for normal glucose reabsorption, theoretical risk to the infant exists.

L-theanine transfer into breast milk has not been systematically studied. Until human lactation data exist, caution is reasonable.

Dose-Timing: Does It Matter for This Pair?

For interactions that are pharmacokinetic (enzyme-based), dose separation sometimes helps. Because the Farxiga and L-theanine interaction is pharmacodynamic and mild, dose separation is not a medically required strategy. You can take them at different times of day if you want the blood-pressure and relaxation effects of L-theanine at a specific point in your schedule (for example, in the evening for sleep), which is actually how most women use it.

Farxiga is typically taken in the morning, with or without food. L-theanine is taken 30-60 minutes before a stressor or at bedtime. Taking them at opposite ends of the day means their blood-pressure effects peak at different times, reducing any theoretical additive risk. This is practical advice, not a strict clinical requirement.

Who This Combination Is and Is Not Right For

Lower-risk candidates

• Women with type 2 diabetes who take Farxiga and want L-theanine for mild anxiety or sleep without sedating medications
• Women with PCOS on Farxiga off-label who experience stress-related cortisol spikes
• Postmenopausal women with well-controlled blood pressure whose prescriber has reviewed their medication list

Higher-monitoring candidates

• Women already on antihypertensive drugs alongside Farxiga, where additive blood-pressure lowering is a real concern
• Women with a history of orthostatic hypotension, autonomic dysfunction, or heart failure with low baseline blood pressure
• Women in perimenopause with significant blood-pressure variability

Not right for

• Pregnant women (Farxiga is contraindicated in 2nd and 3rd trimester; L-theanine lacks safety data)
• Breastfeeding women (both substances carry insufficient lactation safety data)
• Women with severe renal impairment (eGFR <25 mL/min/1.73m²), for whom Farxiga is not indicated for glycemic control; in this group adding any vasodilatory supplement warrants extra caution

Monitoring Checklist If You Take Both

Keeping an eye on a few numbers gives you a clear picture of how your body is responding.

• Blood pressure: Check sitting and standing BP daily for the first two weeks. If standing BP drops more than 20 mmHg compared to sitting, contact your prescriber.
• Symptoms: Note any dizziness, unusual fatigue, or headache after starting L-theanine. These can signal mild hypotension.
• Blood glucose: Standard Farxiga monitoring applies. L-theanine does not require additional glucose checks.
• Genital mycotic infections: A known Farxiga side effect, especially in women. L-theanine does not increase this risk.
• Ketones if you fast: Women on Farxiga who practice intermittent fasting have a higher risk of euglycemic diabetic ketoacidosis. L-theanine does not change this risk, but the lifestyle context matters.

What to Tell Your Prescriber

Bring a complete supplement list to every appointment. For this specific combination, tell your prescriber:

1. The dose and timing of L-theanine you are taking or planning to take.
2. Your current blood-pressure readings, especially if you monitor at home.
3. Any other adaptogens, herbal teas, or supplements you take that might also affect blood pressure or cortisol (ashwagandha, rhodiola, and valerian are common co-users).

A direct quote from the FDA Farxiga prescribing information is relevant here: "Dapagliflozin can cause symptomatic hypotension... Assess and correct volume status before initiating treatment in patients with impaired renal function, elderly patients, or patients on loop diuretics." L-theanine is not a loop diuretic, but the underlying message translates: anything that nudges blood pressure down warrants awareness.

The 2023 ADA Standards of Care recommend that clinicians review all OTC supplements at each visit for patients with diabetes, a recommendation many women find is not consistently applied in short appointments.

WomanRx Editorial Board member Dr. Maya Okafor notes: "Most of my patients taking Farxiga for type 2 diabetes or PCOS don't realize that even 'gentle' supplements like L-theanine can shift blood pressure a few points. That usually isn't a problem, but if you're already on an ACE inhibitor or ARB, two blood-pressure-lowering mechanisms alongside Farxiga is a conversation worth having before you start the supplement, not after."